The risks associated with diabetes in pregnancy include congenital anomalies, stillbirth and miscarriage, and correlate with glycaemia. The optimisation of diabetes during pregnancy is therefore both challenging and essential. Technology has revolutionised how clinicians and patients manage diabetes. This review article focuses on the role of continuous glucose monitoring (CGM) in pregnancy, assessing the evidence available and providing an update on current guidance.
Keywords: pregnancy; Continuous subcutaneous insulin infusion; continuous glucose monitoring; diabetes mellitus; flash glucose monitoring; insulin pump; macrosomia.
© The Author(s) 2021.